Welcome Guest
Home > Clinical Lymphoma & Myeloma > Volume 8 | Supplement 2

Table of Contents

Volume 8 | Supplement 2

Publication Date: December 2007
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Introduction
Page Number of this Article in the Print Version
S42		 Dose-Intense and Dose-Dense Regimens in Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma
Brad Kahl
  • Abstract
  • No Access
  • Add to Cart
Contributions
Page Number of this Article in the Print Version
S43-S49		 Aspects of Chemotherapy Schedules in Young and Elderly Patients with Aggressive Lymphoma
Carsten Zwick, Beate Gleissner, Michael Pfreundschuh
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S50-S56		 Strategies for Improving Outcomes with 14-Day Anthracycline-Based Regimens in Patients with Aggressive Lymphomas
Florence Broussais-Guillaumot, Bertrand Coiffier
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S57-S62		 Update of the M. D. Anderson Cancer Center Experience with Hyper-CVAD and Rituximab for the Treatment of Mantle Cell and Burkitt-Type Lymphomas
Luis Fayad, Deborah Thomas, Jorge Romaguera
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S63-S66		 Prophylactic Use of Filgrastim with ABVD and BEACOPP Chemotherapy Regimens for Hodgkin Lymphoma
Amanda Wedgwood, Anas Younes
  • Abstract
  • No Access
  • Add to Cart